Who Supplies Cabazitaxel? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Cabazitaxel exports, with 59+ registered manufacturers shipping to buyers across 49+ countries — yet a handful of companies dominate the shipments. MSN LABORATORIES PRIVATE LIMITED holds the largest share at 25.7% (export value: $2.4M). Close behind, INTAS PHARMACEUTICALS LIMITED (11.3%, $1.0M). DR REDDY S LABORATORIES LIMITED (11.2%, $1.0M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Cabazitaxel? Top Manufacturers & Their Buyers
Flow of Cabazitaxel from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Cabazitaxel Supplier Network — Key Market Intelligence
The Cabazitaxel export market from India is led by MSN LABORATORIES PRIVATE LIMITED, which alone commands a 25.7% share, shipping $2.4M worth of product across 37 shipments. The second-largest exporter, INTAS PHARMACEUTICALS LIMITED, contributes $1.0M (11.3%) to the overall market. Combined, the top two suppliers alone account for 37.0% of all Cabazitaxel exports, indicating a relatively concentrated supply base.
Across all 59 tracked manufacturers, the total Cabazitaxel export value stands at $9.2M from 307 shipments. The market average shipment value is $30.1K. The single largest buyer relationship in terms of trade value is OOO"JODAS EXPOIM", receiving $2.4M worth of product.
The combined buyer network spans 16 named purchasing companies, including OOO"JODAS EXPOIM", ACCORD HEALTHCARE, SLU, ACCORD HEALTHCARE POLSKA SP. Z O.O., BROCACEF NL HUB, ALLOGA FRANCE and 11 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the first-largest Cabazitaxel exporter from India, with a market share of 25.7% and a total export value of $2.4M across 37 shipments. Their average shipment value of $64.0K is above the market average of $30.1K, suggesting premium or bulk contract pricing.
MSN LABORATORIES PRIVATE LIMITED serves 1 named buyer in our database. OOO"JODAS EXPOIM" is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• OOO"JODAS EXPOIM" — $2.4M across 37 shipments (100.0% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $64.0K is 113% above the market average of $30.1K, consistent with large-order contracts or value-added formulations.
2INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the second-largest Cabazitaxel exporter from India, with a market share of 11.3% and a total export value of $1.0M across 108 shipments. Their average shipment value of $9.7K is below the market average of $30.1K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ACCORD HEALTHCARE, SLU — $287.4K across 30 shipments (27.5% of this supplier's total exports)
• ACCORD HEALTHCARE POLSKA SP. Z O.O. — $275.1K across 28 shipments (26.3% of this supplier's total exports)
• BROCACEF NL HUB — $206.1K across 21 shipments (19.7% of this supplier's total exports)
• ALLOGA FRANCE — $189.9K across 20 shipments (18.1% of this supplier's total exports)
• BROCACEF NL:HUB — $87.9K across 9 shipments (8.4% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (108 shipments) at a per-shipment value of $9.7K, indicating a broad distribution network with many smaller, regular orders.
3DR REDDY S LABORATORIES LIMITED
DR REDDY S LABORATORIES LIMITED is the third-largest Cabazitaxel exporter from India, with a market share of 11.2% and a total export value of $1.0M across 3 shipments. Their average shipment value of $343.1K is above the market average of $30.1K, suggesting premium or bulk contract pricing.
DR REDDY S LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MSN LABS CHILE SPA — $439.6K across 1 shipments (42.7% of this supplier's total exports)
• PHARMADOX HEALTHCARE LIMITED — $175.8K across 1 shipments (17.1% of this supplier's total exports)
• TO THE ORDER OF — $148.7K across 0 shipments (14.4% of this supplier's total exports)
• TILLOMED LABORATORIES LTD — $133.1K across 0 shipments (12.9% of this supplier's total exports)
• PHARMADOX HEALTHCARE LIMITED — $132.1K across 0 shipments (12.8% of this supplier's total exports)
Key Insight: DR REDDY S LABORATORIES LIMITED's per-shipment value of $343.1K is 1042% above the market average of $30.1K, consistent with large-order contracts or value-added formulations.
4DR REDDYS LABORATORIES LIMITED
DR REDDYS LABORATORIES LIMITED is the fourth-largest Cabazitaxel exporter from India, with a market share of 5.7% and a total export value of $524.0K across 3 shipments. Their average shipment value of $174.7K is above the market average of $30.1K, suggesting premium or bulk contract pricing.
DR REDDYS LABORATORIES LIMITED serves 3 named buyers in our database. XX RXXDYSXXRL is the dominant customer, accounting for 71.8% of this supplier's tracked business. Top customers include:
• XX RXXDYSXXRL — $376.0K across 2 shipments (71.8% of this supplier's total exports)
• XXDDYXXHARXX IBXXIA — $93.2K across 1 shipments (17.8% of this supplier's total exports)
• XX REXXYS XXBORXXORI — $54.8K across 0 shipments (10.5% of this supplier's total exports)
Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $174.7K is 481% above the market average of $30.1K, consistent with large-order contracts or value-added formulations.
5INTAS PHARMACEUTICALS LTD
INTAS PHARMACEUTICALS LTD is the fifth-largest Cabazitaxel exporter from India, with a market share of 5.7% and a total export value of $523.6K across 3 shipments. Their average shipment value of $174.5K is above the market average of $30.1K, suggesting premium or bulk contract pricing.
INTAS PHARMACEUTICALS LTD serves 3 named buyers in our database. DR REDDYS S R L is the dominant customer, accounting for 71.8% of this supplier's tracked business. Top customers include:
• DR REDDYS S R L — $375.9K across 2 shipments (71.8% of this supplier's total exports)
• Reddy Pharma Iberia — $93.0K across 1 shipments (17.8% of this supplier's total exports)
• DR REDDY S LABORATOR — $54.7K across 0 shipments (10.4% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LTD's per-shipment value of $174.5K is 481% above the market average of $30.1K, consistent with large-order contracts or value-added formulations.
6BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the fifth-largest Cabazitaxel exporter from India, with a market share of 3.0% and a total export value of $273.9K across 3 shipments. Their average shipment value of $91.3K is above the market average of $30.1K, suggesting premium or bulk contract pricing.
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED serves 3 named buyers in our database. ACCORD HEALTHCARE POLSKA SP. Z O.O. is the dominant customer, accounting for 65.0% of this supplier's tracked business. Top customers include:
• ACCORD HEALTHCARE POLSKA SP. Z O.O. — $178.0K across 2 shipments (65.0% of this supplier's total exports)
• BROCACEF NL HUB BROC — $89.4K across 1 shipments (32.6% of this supplier's total exports)
• PHARMADOX HEALTHCARE LIMITED — $6.5K across 0 shipments (2.4% of this supplier's total exports)
Key Insight: BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED's per-shipment value of $91.3K is 204% above the market average of $30.1K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Cabazitaxel Flows
Once Cabazitaxel leaves the manufacturing plants of companies like MSN LABORATORIES PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $9.2M. Russia absorbs the largest share at 25.7% ($2.4M), followed by Italy (14.8%) and Netherlands (12.9%).
This geographic spread reflects Cabazitaxel's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Cabazitaxel Go? Top Importing Countries & Their Buyers
Trade flow of Cabazitaxel exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Russia
Russia ranks as the first-largest destination for Cabazitaxel imports from India, with a total trade value of $2.4M across 0 shipments — representing a 25.7% share of all Cabazitaxel exports. The average shipment value of $2.4M is above the global average of $30.1K, indicating high-value procurement contracts or branded formulations.
Key Insight: Russia's per-shipment average of $2.4M (7781% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Cabazitaxel imports from India.
2Italy
Italy ranks as the second-largest destination for Cabazitaxel imports from India, with a total trade value of $1.4M across 2 shipments — representing a 14.8% share of all Cabazitaxel exports. The average shipment value of $683.2K is above the global average of $30.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Cabazitaxel importers in Italy: ACCORD HEALTHCARE ITALIA SRL. is the largest buyer, accounting for 33.0% ($451.6K) of this market's total imports.
• ACCORD HEALTHCARE ITALIA SRL. — $451.6K (33.0% of Italy's total)
Key Insight: Italy's per-shipment average of $683.2K (2173% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Italy is a key market for Cabazitaxel imports from India.
3Netherlands
Netherlands ranks as the third-largest destination for Cabazitaxel imports from India, with a total trade value of $1.2M across 15 shipments — representing a 12.9% share of all Cabazitaxel exports. The average shipment value of $79.4K is above the global average of $30.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Cabazitaxel importers in Netherlands: ALLOGA FRANCE is the largest buyer, accounting for 32.4% ($386.4K) of this market's total imports.
• ALLOGA FRANCE — $386.4K (32.4% of Netherlands's total)
• BROCACEF NL HUB — $275.7K (23.1% of Netherlands's total)
• BROCACEF NL:HUB — $228.4K (19.2% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $79.4K (164% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Cabazitaxel imports from India.
4Poland
Poland ranks as the fourth-largest destination for Cabazitaxel imports from India, with a total trade value of $1.1M across 4 shipments — representing a 11.4% share of all Cabazitaxel exports. The average shipment value of $263.7K is above the global average of $30.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Cabazitaxel importers in Poland: ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the largest buyer, accounting for 54.4% ($573.9K) of this market's total imports.
• ACCORD HEALTHCARE POLSKA SP. Z.O.O. — $573.9K (54.4% of Poland's total)
• ACCORD HEALTHCARE POLSKA SP. Z O.O. — $295.8K (28.0% of Poland's total)
Key Insight: Poland's per-shipment average of $263.7K (777% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Poland is a key market for Cabazitaxel imports from India.
5Malta
Malta ranks as the fifth-largest destination for Cabazitaxel imports from India, with a total trade value of $788.4K across 44 shipments — representing a 8.5% share of all Cabazitaxel exports. The average shipment value of $17.9K is below the global average of $30.1K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Cabazitaxel importers in Malta: PHARMADOX HEALTHCARE LTD is the largest buyer, accounting for 33.4% ($263.2K) of this market's total imports.
• PHARMADOX HEALTHCARE LTD — $263.2K (33.4% of Malta's total)
• PHARMADOX HEALTHCARE LIMITED — $159.8K (20.3% of Malta's total)
Key Insight: Malta receives frequent, smaller shipments of Cabazitaxel — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Malta is a key market for Cabazitaxel imports from India.
People Also Ask — Cabazitaxel Supplier & Trade Network
Who are the top suppliers of Cabazitaxel from India?+
Which companies buy Cabazitaxel from Indian manufacturers?+
Where does Cabazitaxel exported from India go?+
What is the market share of the top Cabazitaxel supplier from India?+
What is the average shipment value for Cabazitaxel exports from India?+
Is Cabazitaxel manufactured in India and exported globally?+
Which country imports the most Cabazitaxel from India?+
Who are the buyers of Cabazitaxel in Italy?+
How concentrated is the Cabazitaxel supplier market in India?+
How do I find verified buyers for Cabazitaxel in specific countries?+
Cabazitaxel Trade Network — Key Takeaways
- 1MSN LABORATORIES PRIVATE LIMITED is India's dominant Cabazitaxel exporter with a 25.7% market share and $2.4M in total exports — making it the single most important sourcing entity in this market.
- 2The top 59 suppliers collectively account for 62.5% of all tracked Cabazitaxel exports, with a combined trade value of $9.2M.
- 3Russia is the largest destination market, absorbing 25.7% of India's Cabazitaxel exports ($2.4M). Italy (14.8%) and Netherlands (12.9%) follow.
- 4With 307 total shipments averaging $30.1K each, the Cabazitaxel export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include OOO"JODAS EXPOIM", ACCORD HEALTHCARE, SLU, ACCORD HEALTHCARE POLSKA SP. Z O.O., MSN LABS CHILE SPA — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 49 countries
Network value: $9.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cabazitaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Cabazitaxel.
- 2.Flow Mapping: 59 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 307 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 49 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
307 Verified Shipments
59 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists